| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |